Sumitomo Chemical India Moat Analysis: Score & Risks
Sumitomo Chemical India Ltd.
A first-pass moat teardown of Sumitomo Chemical India Ltd., built from single-pass filing evidence. Free note — provisional, and the full two-pass deep dive may revise it.
First-pass narrow-to-wide read — primary edge in Cost Advantage. Provisional, single-pass evidence.
Sumitomo Chemical India Ltd. scores 5.85 on MoatSCORE 6.0 — a narrow-to-wide moat in Chemicals. This is a first-pass note: the dimensional read and the filing receipts below come from a single GFIP evidence pass, not the full two-pass deep corpus behind our flagship deep dives. Provisional — published free while the deep version is queued.
Seven dimensions of moat
Ordered by contribution. Each dimension carries a verified filing quote, graded [M] mechanism or [O] outcome.
“Backward integration for some of the existing molecules/intermediates to attain self-sufficiency and to remain competitive.”
“We have five manufacturing facilities in India ì.e. Bhavnagar, Gajod, Tarapur, Vapi and Silvasa. We have three fully equipped DSIR approved R&D facilities.”
“We continue to focus on disciplined sales through monitoring ground level liquidation, consumption patterns and disciplined credit policies along with collections from channel partners.”
“maintaining complete pricing integrity, and recording only negligible channel returns, even as the Company consciously declined to dump material in pursuit of short-term volume”
“the patented, proprietary technologies Excalia Max and Lentigo from our parent's portfolio”
“registration is always a situation beyond our hands so maybe in one year there will be two products or one year the product can be delayed that thing can happen”
D8 rating: ADEQUATE. Not part of the moat score — it governs the cost of equity and the fade window. First-pass; not yet deep-reviewed.
The barrier gate — first-pass
Effective barrier 6 — at or above 6, consistent with a narrow-to-wide read. First-pass estimate.
Deep two-pass review. This draft rests on a single GFIP evidence pass; the full 10-year AR + concall corpus may move the read.
The barrier gate. A firmer replication or bypass estimate is the most likely thing to shift the band.
Adverse events. Any governance, regulatory or funding shock captured in D8 could re-rate the fade window.
Where this note fits. This company is one of 509 Indian companies we have scored for moat durability — 370 narrow, 126 narrow-trending-wide, none wide. Every score, dimension by dimension, is free in the Moat Screener.
Member discussion